[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global N-Pentadecane Market Insights, Forecast to 2029

December 2023 | 96 pages | ID: G152489EE6A2EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for N-Pentadecane, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of N-Pentadecane, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for N-Pentadecane, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the N-Pentadecane sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global N-Pentadecane market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for N-Pentadecane sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Merck, Alfa Aesar, Eurisotop, Scharlab, AccuStandard, HPC Standards GmbH and BLD Pharmatech Ltd, etc.

By Company
  • Merck
  • Alfa Aesar
  • Eurisotop
  • Scharlab
  • AccuStandard
  • HPC Standards GmbH
  • BLD Pharmatech Ltd
Segment by Type
  • Purity 98%
  • Purity 99%
  • Others
Segment by Application
  • Industrial Application
  • Chemical Industry
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • US & Canada
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • China Taiwan
  • Southeast Asia
    • India
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Turkey
    • Israel
    • GCC Countries
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: N-Pentadecane production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of N-Pentadecane in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of N-Pentadecane manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 9: China by type and by application sales and revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, N-Pentadecane sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.
1 STUDY COVERAGE

1.1 N-Pentadecane Product Introduction
1.2 Market by Type
  1.2.1 Global N-Pentadecane Market Size by Type, 2018 VS 2022 VS 2029
  1.2.2 Purity 98%
  1.2.3 Purity 99%
  1.2.4 Others
1.3 Market by Application
  1.3.1 Global N-Pentadecane Market Size by Application, 2018 VS 2022 VS 2029
  1.3.2 Industrial Application
  1.3.3 Chemical Industry
  1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 GLOBAL N-PENTADECANE PRODUCTION

2.1 Global N-Pentadecane Production Capacity (2018-2029)
2.2 Global N-Pentadecane Production by Region: 2018 VS 2022 VS 2029
2.3 Global N-Pentadecane Production by Region
  2.3.1 Global N-Pentadecane Historic Production by Region (2018-2023)
  2.3.2 Global N-Pentadecane Forecasted Production by Region (2024-2029)
  2.3.3 Global N-Pentadecane Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan

3 EXECUTIVE SUMMARY

3.1 Global N-Pentadecane Revenue Estimates and Forecasts 2018-2029
3.2 Global N-Pentadecane Revenue by Region
  3.2.1 Global N-Pentadecane Revenue by Region: 2018 VS 2022 VS 2029
  3.2.2 Global N-Pentadecane Revenue by Region (2018-2023)
  3.2.3 Global N-Pentadecane Revenue by Region (2024-2029)
  3.2.4 Global N-Pentadecane Revenue Market Share by Region (2018-2029)
3.3 Global N-Pentadecane Sales Estimates and Forecasts 2018-2029
3.4 Global N-Pentadecane Sales by Region
  3.4.1 Global N-Pentadecane Sales by Region: 2018 VS 2022 VS 2029
  3.4.2 Global N-Pentadecane Sales by Region (2018-2023)
  3.4.3 Global N-Pentadecane Sales by Region (2024-2029)
  3.4.4 Global N-Pentadecane Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America

4 COMPETITION BY MANUFACTURES

4.1 Global N-Pentadecane Sales by Manufacturers
  4.1.1 Global N-Pentadecane Sales by Manufacturers (2018-2023)
  4.1.2 Global N-Pentadecane Sales Market Share by Manufacturers (2018-2023)
  4.1.3 Global Top 10 and Top 5 Largest Manufacturers of N-Pentadecane in 2022
4.2 Global N-Pentadecane Revenue by Manufacturers
  4.2.1 Global N-Pentadecane Revenue by Manufacturers (2018-2023)
  4.2.2 Global N-Pentadecane Revenue Market Share by Manufacturers (2018-2023)
  4.2.3 Global Top 10 and Top 5 Companies by N-Pentadecane Revenue in 2022
4.3 Global N-Pentadecane Sales Price by Manufacturers
4.4 Global Key Players of N-Pentadecane, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
  4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  4.5.2 Global N-Pentadecane Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of N-Pentadecane, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of N-Pentadecane, Product Offered and Application
4.8 Global Key Manufacturers of N-Pentadecane, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans

5 MARKET SIZE BY TYPE

5.1 Global N-Pentadecane Sales by Type
  5.1.1 Global N-Pentadecane Historical Sales by Type (2018-2023)
  5.1.2 Global N-Pentadecane Forecasted Sales by Type (2024-2029)
  5.1.3 Global N-Pentadecane Sales Market Share by Type (2018-2029)
5.2 Global N-Pentadecane Revenue by Type
  5.2.1 Global N-Pentadecane Historical Revenue by Type (2018-2023)
  5.2.2 Global N-Pentadecane Forecasted Revenue by Type (2024-2029)
  5.2.3 Global N-Pentadecane Revenue Market Share by Type (2018-2029)
5.3 Global N-Pentadecane Price by Type
  5.3.1 Global N-Pentadecane Price by Type (2018-2023)
  5.3.2 Global N-Pentadecane Price Forecast by Type (2024-2029)

6 MARKET SIZE BY APPLICATION

6.1 Global N-Pentadecane Sales by Application
  6.1.1 Global N-Pentadecane Historical Sales by Application (2018-2023)
  6.1.2 Global N-Pentadecane Forecasted Sales by Application (2024-2029)
  6.1.3 Global N-Pentadecane Sales Market Share by Application (2018-2029)
6.2 Global N-Pentadecane Revenue by Application
  6.2.1 Global N-Pentadecane Historical Revenue by Application (2018-2023)
  6.2.2 Global N-Pentadecane Forecasted Revenue by Application (2024-2029)
  6.2.3 Global N-Pentadecane Revenue Market Share by Application (2018-2029)
6.3 Global N-Pentadecane Price by Application
  6.3.1 Global N-Pentadecane Price by Application (2018-2023)
  6.3.2 Global N-Pentadecane Price Forecast by Application (2024-2029)

7 US & CANADA

7.1 US & Canada N-Pentadecane Market Size by Type
  7.1.1 US & Canada N-Pentadecane Sales by Type (2018-2029)
  7.1.2 US & Canada N-Pentadecane Revenue by Type (2018-2029)
7.2 US & Canada N-Pentadecane Market Size by Application
  7.2.1 US & Canada N-Pentadecane Sales by Application (2018-2029)
  7.2.2 US & Canada N-Pentadecane Revenue by Application (2018-2029)
7.3 US & Canada N-Pentadecane Sales by Country
  7.3.1 US & Canada N-Pentadecane Revenue by Country: 2018 VS 2022 VS 2029
  7.3.2 US & Canada N-Pentadecane Sales by Country (2018-2029)
  7.3.3 US & Canada N-Pentadecane Revenue by Country (2018-2029)
  7.3.4 United States
  7.3.5 Canada

8 EUROPE

8.1 Europe N-Pentadecane Market Size by Type
  8.1.1 Europe N-Pentadecane Sales by Type (2018-2029)
  8.1.2 Europe N-Pentadecane Revenue by Type (2018-2029)
8.2 Europe N-Pentadecane Market Size by Application
  8.2.1 Europe N-Pentadecane Sales by Application (2018-2029)
  8.2.2 Europe N-Pentadecane Revenue by Application (2018-2029)
8.3 Europe N-Pentadecane Sales by Country
  8.3.1 Europe N-Pentadecane Revenue by Country: 2018 VS 2022 VS 2029
  8.3.2 Europe N-Pentadecane Sales by Country (2018-2029)
  8.3.3 Europe N-Pentadecane Revenue by Country (2018-2029)
  8.3.4 Germany
  8.3.5 France
  8.3.6 U.K.
  8.3.7 Italy
  8.3.8 Russia

9 CHINA

9.1 China N-Pentadecane Market Size by Type
  9.1.1 China N-Pentadecane Sales by Type (2018-2029)
  9.1.2 China N-Pentadecane Revenue by Type (2018-2029)
9.2 China N-Pentadecane Market Size by Application
  9.2.1 China N-Pentadecane Sales by Application (2018-2029)
  9.2.2 China N-Pentadecane Revenue by Application (2018-2029)

10 ASIA (EXCLUDING CHINA)

10.1 Asia N-Pentadecane Market Size by Type
  10.1.1 Asia N-Pentadecane Sales by Type (2018-2029)
  10.1.2 Asia N-Pentadecane Revenue by Type (2018-2029)
10.2 Asia N-Pentadecane Market Size by Application
  10.2.1 Asia N-Pentadecane Sales by Application (2018-2029)
  10.2.2 Asia N-Pentadecane Revenue by Application (2018-2029)
10.3 Asia N-Pentadecane Sales by Region
  10.3.1 Asia N-Pentadecane Revenue by Region: 2018 VS 2022 VS 2029
  10.3.2 Asia N-Pentadecane Revenue by Region (2018-2029)
  10.3.3 Asia N-Pentadecane Sales by Region (2018-2029)
  10.3.4 Japan
  10.3.5 South Korea
  10.3.6 China Taiwan
  10.3.7 Southeast Asia
  10.3.8 India

11 MIDDLE EAST, AFRICA AND LATIN AMERICA

11.1 Middle East, Africa and Latin America N-Pentadecane Market Size by Type
  11.1.1 Middle East, Africa and Latin America N-Pentadecane Sales by Type (2018-2029)
  11.1.2 Middle East, Africa and Latin America N-Pentadecane Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America N-Pentadecane Market Size by Application
  11.2.1 Middle East, Africa and Latin America N-Pentadecane Sales by Application (2018-2029)
  11.2.2 Middle East, Africa and Latin America N-Pentadecane Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America N-Pentadecane Sales by Country
  11.3.1 Middle East, Africa and Latin America N-Pentadecane Revenue by Country: 2018 VS 2022 VS 2029
  11.3.2 Middle East, Africa and Latin America N-Pentadecane Revenue by Country (2018-2029)
  11.3.3 Middle East, Africa and Latin America N-Pentadecane Sales by Country (2018-2029)
  11.3.4 Brazil
  11.3.5 Mexico
  11.3.6 Turkey
  11.3.7 Israel
  11.3.8 GCC Countries

12 CORPORATE PROFILES

12.1 Merck
  12.1.1 Merck Company Information
  12.1.2 Merck Overview
  12.1.3 Merck N-Pentadecane Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.1.4 Merck N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
  12.1.5 Merck Recent Developments
12.2 Alfa Aesar
  12.2.1 Alfa Aesar Company Information
  12.2.2 Alfa Aesar Overview
  12.2.3 Alfa Aesar N-Pentadecane Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.2.4 Alfa Aesar N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
  12.2.5 Alfa Aesar Recent Developments
12.3 Eurisotop
  12.3.1 Eurisotop Company Information
  12.3.2 Eurisotop Overview
  12.3.3 Eurisotop N-Pentadecane Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.3.4 Eurisotop N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
  12.3.5 Eurisotop Recent Developments
12.4 Scharlab
  12.4.1 Scharlab Company Information
  12.4.2 Scharlab Overview
  12.4.3 Scharlab N-Pentadecane Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.4.4 Scharlab N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
  12.4.5 Scharlab Recent Developments
12.5 AccuStandard
  12.5.1 AccuStandard Company Information
  12.5.2 AccuStandard Overview
  12.5.3 AccuStandard N-Pentadecane Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.5.4 AccuStandard N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
  12.5.5 AccuStandard Recent Developments
12.6 HPC Standards GmbH
  12.6.1 HPC Standards GmbH Company Information
  12.6.2 HPC Standards GmbH Overview
  12.6.3 HPC Standards GmbH N-Pentadecane Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.6.4 HPC Standards GmbH N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
  12.6.5 HPC Standards GmbH Recent Developments
12.7 BLD Pharmatech Ltd
  12.7.1 BLD Pharmatech Ltd Company Information
  12.7.2 BLD Pharmatech Ltd Overview
  12.7.3 BLD Pharmatech Ltd N-Pentadecane Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.7.4 BLD Pharmatech Ltd N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
  12.7.5 BLD Pharmatech Ltd Recent Developments

13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

13.1 N-Pentadecane Industry Chain Analysis
13.2 N-Pentadecane Key Raw Materials
  13.2.1 Key Raw Materials
  13.2.2 Raw Materials Key Suppliers
13.3 N-Pentadecane Production Mode & Process
13.4 N-Pentadecane Sales and Marketing
  13.4.1 N-Pentadecane Sales Channels
  13.4.2 N-Pentadecane Distributors
13.5 N-Pentadecane Customers

14 N-PENTADECANE MARKET DYNAMICS

14.1 N-Pentadecane Industry Trends
14.2 N-Pentadecane Market Drivers
14.3 N-Pentadecane Market Challenges
14.4 N-Pentadecane Market Restraints

15 KEY FINDING IN THE GLOBAL N-PENTADECANE STUDY


16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

LIST OF TABLES

Table 1. Global N-Pentadecane Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Purity 98%
Table 3. Major Manufacturers of Purity 99%
Table 4. Major Manufacturers of Others
Table 5. Global N-Pentadecane Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global N-Pentadecane Production by Region: 2018 VS 2022 VS 2029 (Kiloton)
Table 7. Global N-Pentadecane Production by Region (2018-2023) & (Kiloton)
Table 8. Global N-Pentadecane Production by Region (2024-2029) & (Kiloton)
Table 9. Global N-Pentadecane Production Market Share by Region (2018-2023)
Table 10. Global N-Pentadecane Production Market Share by Region (2024-2029)
Table 11. Global N-Pentadecane Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global N-Pentadecane Revenue by Region (2018-2023) & (US$ Million)
Table 13. Global N-Pentadecane Revenue by Region (2024-2029) & (US$ Million)
Table 14. Global N-Pentadecane Revenue Market Share by Region (2018-2023)
Table 15. Global N-Pentadecane Revenue Market Share by Region (2024-2029)
Table 16. Global N-Pentadecane Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 17. Global N-Pentadecane Sales by Region (2018-2023) & (Kiloton)
Table 18. Global N-Pentadecane Sales by Region (2024-2029) & (Kiloton)
Table 19. Global N-Pentadecane Sales Market Share by Region (2018-2023)
Table 20. Global N-Pentadecane Sales Market Share by Region (2024-2029)
Table 21. Global N-Pentadecane Sales by Manufacturers (2018-2023) & (Kiloton)
Table 22. Global N-Pentadecane Sales Share by Manufacturers (2018-2023)
Table 23. Global N-Pentadecane Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 24. Global N-Pentadecane Revenue Share by Manufacturers (2018-2023)
Table 25. N-Pentadecane Price by Manufacturers 2018-2023 (US$/Ton)
Table 26. Global Key Players of N-Pentadecane, Industry Ranking, 2021 VS 2022 VS 2023
Table 27. Global N-Pentadecane Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global N-Pentadecane by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in N-Pentadecane as of 2022)
Table 29. Global Key Manufacturers of N-Pentadecane, Manufacturing Base Distribution and Headquarters
Table 30. Global Key Manufacturers of N-Pentadecane, Product Offered and Application
Table 31. Global Key Manufacturers of N-Pentadecane, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global N-Pentadecane Sales by Type (2018-2023) & (Kiloton)
Table 34. Global N-Pentadecane Sales by Type (2024-2029) & (Kiloton)
Table 35. Global N-Pentadecane Sales Share by Type (2018-2023)
Table 36. Global N-Pentadecane Sales Share by Type (2024-2029)
Table 37. Global N-Pentadecane Revenue by Type (2018-2023) & (US$ Million)
Table 38. Global N-Pentadecane Revenue by Type (2024-2029) & (US$ Million)
Table 39. Global N-Pentadecane Revenue Share by Type (2018-2023)
Table 40. Global N-Pentadecane Revenue Share by Type (2024-2029)
Table 41. N-Pentadecane Price by Type (2018-2023) & (US$/Ton)
Table 42. Global N-Pentadecane Price Forecast by Type (2024-2029) & (US$/Ton)
Table 43. Global N-Pentadecane Sales by Application (2018-2023) & (Kiloton)
Table 44. Global N-Pentadecane Sales by Application (2024-2029) & (Kiloton)
Table 45. Global N-Pentadecane Sales Share by Application (2018-2023)
Table 46. Global N-Pentadecane Sales Share by Application (2024-2029)
Table 47. Global N-Pentadecane Revenue by Application (2018-2023) & (US$ Million)
Table 48. Global N-Pentadecane Revenue by Application (2024-2029) & (US$ Million)
Table 49. Global N-Pentadecane Revenue Share by Application (2018-2023)
Table 50. Global N-Pentadecane Revenue Share by Application (2024-2029)
Table 51. N-Pentadecane Price by Application (2018-2023) & (US$/Ton)
Table 52. Global N-Pentadecane Price Forecast by Application (2024-2029) & (US$/Ton)
Table 53. US & Canada N-Pentadecane Sales by Type (2018-2023) & (Kiloton)
Table 54. US & Canada N-Pentadecane Sales by Type (2024-2029) & (Kiloton)
Table 55. US & Canada N-Pentadecane Revenue by Type (2018-2023) & (US$ Million)
Table 56. US & Canada N-Pentadecane Revenue by Type (2024-2029) & (US$ Million)
Table 57. US & Canada N-Pentadecane Sales by Application (2018-2023) & (Kiloton)
Table 58. US & Canada N-Pentadecane Sales by Application (2024-2029) & (Kiloton)
Table 59. US & Canada N-Pentadecane Revenue by Application (2018-2023) & (US$ Million)
Table 60. US & Canada N-Pentadecane Revenue by Application (2024-2029) & (US$ Million)
Table 61. US & Canada N-Pentadecane Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 62. US & Canada N-Pentadecane Revenue by Country (2018-2023) & (US$ Million)
Table 63. US & Canada N-Pentadecane Revenue by Country (2024-2029) & (US$ Million)
Table 64. US & Canada N-Pentadecane Sales by Country (2018-2023) & (Kiloton)
Table 65. US & Canada N-Pentadecane Sales by Country (2024-2029) & (Kiloton)
Table 66. Europe N-Pentadecane Sales by Type (2018-2023) & (Kiloton)
Table 67. Europe N-Pentadecane Sales by Type (2024-2029) & (Kiloton)
Table 68. Europe N-Pentadecane Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe N-Pentadecane Revenue by Type (2024-2029) & (US$ Million)
Table 70. Europe N-Pentadecane Sales by Application (2018-2023) & (Kiloton)
Table 71. Europe N-Pentadecane Sales by Application (2024-2029) & (Kiloton)
Table 72. Europe N-Pentadecane Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe N-Pentadecane Revenue by Application (2024-2029) & (US$ Million)
Table 74. Europe N-Pentadecane Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 75. Europe N-Pentadecane Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe N-Pentadecane Revenue by Country (2024-2029) & (US$ Million)
Table 77. Europe N-Pentadecane Sales by Country (2018-2023) & (Kiloton)
Table 78. Europe N-Pentadecane Sales by Country (2024-2029) & (Kiloton)
Table 79. China N-Pentadecane Sales by Type (2018-2023) & (Kiloton)
Table 80. China N-Pentadecane Sales by Type (2024-2029) & (Kiloton)
Table 81. China N-Pentadecane Revenue by Type (2018-2023) & (US$ Million)
Table 82. China N-Pentadecane Revenue by Type (2024-2029) & (US$ Million)
Table 83. China N-Pentadecane Sales by Application (2018-2023) & (Kiloton)
Table 84. China N-Pentadecane Sales by Application (2024-2029) & (Kiloton)
Table 85. China N-Pentadecane Revenue by Application (2018-2023) & (US$ Million)
Table 86. China N-Pentadecane Revenue by Application (2024-2029) & (US$ Million)
Table 87. Asia N-Pentadecane Sales by Type (2018-2023) & (Kiloton)
Table 88. Asia N-Pentadecane Sales by Type (2024-2029) & (Kiloton)
Table 89. Asia N-Pentadecane Revenue by Type (2018-2023) & (US$ Million)
Table 90. Asia N-Pentadecane Revenue by Type (2024-2029) & (US$ Million)
Table 91. Asia N-Pentadecane Sales by Application (2018-2023) & (Kiloton)
Table 92. Asia N-Pentadecane Sales by Application (2024-2029) & (Kiloton)
Table 93. Asia N-Pentadecane Revenue by Application (2018-2023) & (US$ Million)
Table 94. Asia N-Pentadecane Revenue by Application (2024-2029) & (US$ Million)
Table 95. Asia N-Pentadecane Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Asia N-Pentadecane Revenue by Region (2018-2023) & (US$ Million)
Table 97. Asia N-Pentadecane Revenue by Region (2024-2029) & (US$ Million)
Table 98. Asia N-Pentadecane Sales by Region (2018-2023) & (Kiloton)
Table 99. Asia N-Pentadecane Sales by Region (2024-2029) & (Kiloton)
Table 100. Middle East, Africa and Latin America N-Pentadecane Sales by Type (2018-2023) & (Kiloton)
Table 101. Middle East, Africa and Latin America N-Pentadecane Sales by Type (2024-2029) & (Kiloton)
Table 102. Middle East, Africa and Latin America N-Pentadecane Revenue by Type (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America N-Pentadecane Revenue by Type (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America N-Pentadecane Sales by Application (2018-2023) & (Kiloton)
Table 105. Middle East, Africa and Latin America N-Pentadecane Sales by Application (2024-2029) & (Kiloton)
Table 106. Middle East, Africa and Latin America N-Pentadecane Revenue by Application (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America N-Pentadecane Revenue by Application (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America N-Pentadecane Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 109. Middle East, Africa and Latin America N-Pentadecane Revenue by Country (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America N-Pentadecane Revenue by Country (2024-2029) & (US$ Million)
Table 111. Middle East, Africa and Latin America N-Pentadecane Sales by Country (2018-2023) & (Kiloton)
Table 112. Middle East, Africa and Latin America N-Pentadecane Sales by Country (2024-2029) & (Kiloton)
Table 113. Merck Company Information
Table 114. Merck Description and Major Businesses
Table 115. Merck N-Pentadecane Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Merck N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Merck Recent Development
Table 118. Alfa Aesar Company Information
Table 119. Alfa Aesar Description and Major Businesses
Table 120. Alfa Aesar N-Pentadecane Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Alfa Aesar N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Alfa Aesar Recent Development
Table 123. Eurisotop Company Information
Table 124. Eurisotop Description and Major Businesses
Table 125. Eurisotop N-Pentadecane Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Eurisotop N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Eurisotop Recent Development
Table 128. Scharlab Company Information
Table 129. Scharlab Description and Major Businesses
Table 130. Scharlab N-Pentadecane Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Scharlab N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Scharlab Recent Development
Table 133. AccuStandard Company Information
Table 134. AccuStandard Description and Major Businesses
Table 135. AccuStandard N-Pentadecane Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. AccuStandard N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. AccuStandard Recent Development
Table 138. HPC Standards GmbH Company Information
Table 139. HPC Standards GmbH Description and Major Businesses
Table 140. HPC Standards GmbH N-Pentadecane Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. HPC Standards GmbH N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. HPC Standards GmbH Recent Development
Table 143. BLD Pharmatech Ltd Company Information
Table 144. BLD Pharmatech Ltd Description and Major Businesses
Table 145. BLD Pharmatech Ltd N-Pentadecane Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. BLD Pharmatech Ltd N-Pentadecane Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. BLD Pharmatech Ltd Recent Development
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. N-Pentadecane Distributors List
Table 151. N-Pentadecane Customers List
Table 152. N-Pentadecane Market Trends
Table 153. N-Pentadecane Market Drivers
Table 154. N-Pentadecane Market Challenges
Table 155. N-Pentadecane Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. N-Pentadecane Product Picture
Figure 2. Global N-Pentadecane Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global N-Pentadecane Market Share by Type in 2022 & 2029
Figure 4. Purity 98% Product Picture
Figure 5. Purity 99% Product Picture
Figure 6. Others Product Picture
Figure 7. Global N-Pentadecane Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global N-Pentadecane Market Share by Application in 2022 & 2029
Figure 9. Industrial Application
Figure 10. Chemical Industry
Figure 11. Others
Figure 12. N-Pentadecane Report Years Considered
Figure 13. Global N-Pentadecane Capacity, Production and Utilization (2018-2029) & (Kiloton)
Figure 14. Global N-Pentadecane Production Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global N-Pentadecane Production Market Share by Region (2018-2029)
Figure 16. N-Pentadecane Production Growth Rate in North America (2018-2029) & (Kiloton)
Figure 17. N-Pentadecane Production Growth Rate in Europe (2018-2029) & (Kiloton)
Figure 18. N-Pentadecane Production Growth Rate in China (2018-2029) & (Kiloton)
Figure 19. N-Pentadecane Production Growth Rate in Japan (2018-2029) & (Kiloton)
Figure 20. Global N-Pentadecane Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global N-Pentadecane Revenue 2018-2029 (US$ Million)
Figure 22. Global N-Pentadecane Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 23. Global N-Pentadecane Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 24. Global N-Pentadecane Revenue Market Share by Region (2018-2029)
Figure 25. Global N-Pentadecane Sales 2018-2029 ((Kiloton)
Figure 26. Global N-Pentadecane Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (Kiloton)
Figure 27. Global N-Pentadecane Sales Market Share by Region (2018-2029)
Figure 28. US & Canada N-Pentadecane Sales YoY (2018-2029) & (Kiloton)
Figure 29. US & Canada N-Pentadecane Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Europe N-Pentadecane Sales YoY (2018-2029) & (Kiloton)
Figure 31. Europe N-Pentadecane Revenue YoY (2018-2029) & (US$ Million)
Figure 32. China N-Pentadecane Sales YoY (2018-2029) & (Kiloton)
Figure 33. China N-Pentadecane Revenue YoY (2018-2029) & (US$ Million)
Figure 34. Asia (excluding China) N-Pentadecane Sales YoY (2018-2029) & (Kiloton)
Figure 35. Asia (excluding China) N-Pentadecane Revenue YoY (2018-2029) & (US$ Million)
Figure 36. Middle East, Africa and Latin America N-Pentadecane Sales YoY (2018-2029) & (Kiloton)
Figure 37. Middle East, Africa and Latin America N-Pentadecane Revenue YoY (2018-2029) & (US$ Million)
Figure 38. The N-Pentadecane Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 39. The Top 5 and 10 Largest Manufacturers of N-Pentadecane in the World: Market Share by N-Pentadecane Revenue in 2022
Figure 40. Global N-Pentadecane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 41. Global N-Pentadecane Sales Market Share by Type (2018-2029)
Figure 42. Global N-Pentadecane Revenue Market Share by Type (2018-2029)
Figure 43. Global N-Pentadecane Sales Market Share by Application (2018-2029)
Figure 44. Global N-Pentadecane Revenue Market Share by Application (2018-2029)
Figure 45. US & Canada N-Pentadecane Sales Market Share by Type (2018-2029)
Figure 46. US & Canada N-Pentadecane Revenue Market Share by Type (2018-2029)
Figure 47. US & Canada N-Pentadecane Sales Market Share by Application (2018-2029)
Figure 48. US & Canada N-Pentadecane Revenue Market Share by Application (2018-2029)
Figure 49. US & Canada N-Pentadecane Revenue Share by Country (2018-2029)
Figure 50. US & Canada N-Pentadecane Sales Share by Country (2018-2029)
Figure 51. U.S. N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 52. Canada N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 53. Europe N-Pentadecane Sales Market Share by Type (2018-2029)
Figure 54. Europe N-Pentadecane Revenue Market Share by Type (2018-2029)
Figure 55. Europe N-Pentadecane Sales Market Share by Application (2018-2029)
Figure 56. Europe N-Pentadecane Revenue Market Share by Application (2018-2029)
Figure 57. Europe N-Pentadecane Revenue Share by Country (2018-2029)
Figure 58. Europe N-Pentadecane Sales Share by Country (2018-2029)
Figure 59. Germany N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 60. France N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 61. U.K. N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 62. Italy N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 63. Russia N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 64. China N-Pentadecane Sales Market Share by Type (2018-2029)
Figure 65. China N-Pentadecane Revenue Market Share by Type (2018-2029)
Figure 66. China N-Pentadecane Sales Market Share by Application (2018-2029)
Figure 67. China N-Pentadecane Revenue Market Share by Application (2018-2029)
Figure 68. Asia N-Pentadecane Sales Market Share by Type (2018-2029)
Figure 69. Asia N-Pentadecane Revenue Market Share by Type (2018-2029)
Figure 70. Asia N-Pentadecane Sales Market Share by Application (2018-2029)
Figure 71. Asia N-Pentadecane Revenue Market Share by Application (2018-2029)
Figure 72. Asia N-Pentadecane Revenue Share by Region (2018-2029)
Figure 73. Asia N-Pentadecane Sales Share by Region (2018-2029)
Figure 74. Japan N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 75. South Korea N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 76. China Taiwan N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 77. Southeast Asia N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 78. India N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 79. Middle East, Africa and Latin America N-Pentadecane Sales Market Share by Type (2018-2029)
Figure 80. Middle East, Africa and Latin America N-Pentadecane Revenue Market Share by Type (2018-2029)
Figure 81. Middle East, Africa and Latin America N-Pentadecane Sales Market Share by Application (2018-2029)
Figure 82. Middle East, Africa and Latin America N-Pentadecane Revenue Market Share by Application (2018-2029)
Figure 83. Middle East, Africa and Latin America N-Pentadecane Revenue Share by Country (2018-2029)
Figure 84. Middle East, Africa and Latin America N-Pentadecane Sales Share by Country (2018-2029)
Figure 85. Brazil N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 86. Mexico N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 87. Turkey N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 88. Israel N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 89. GCC Countries N-Pentadecane Revenue (2018-2029) & (US$ Million)
Figure 90. N-Pentadecane Value Chain
Figure 91. N-Pentadecane Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed


More Publications